Metraipolis › archive › dc_7248cc123f28
HLA-B*58:01 and Risk of Allopurinol-Induced Severe Cutaneous Adverse Reactions in the US — Europe PMC PMID:41160012
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41160012
- DOI
- 10.1001/jamadermatol.2025.4240
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T02:30:46.259Z
- SHA-256 of the archived text
c28f5664ad1d43091f13086201bb81175e5b2aae1311eb2e6ac553b2bc164093- Stable URL of this page
https://metraipolis.com/documento/dc_7248cc123f28
How to cite
HLA-B*58:01 and Risk of Allopurinol-Induced Severe Cutaneous Adverse Reactions in the US — Europe PMC PMID:41160012 — Europe PMC (en), https://europepmc.org/article/MED/41160012 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7248cc123f28 (Metraipolis archive dc_7248cc123f28, sha256 c28f5664ad1d43091f13086201bb81175e5b2aae1311eb2e6ac553b2bc164093)
BibTeX
@misc{dc7248cc123f28,
title = {HLA-B*58:01 and Risk of Allopurinol-Induced Severe Cutaneous Adverse Reactions in the US — Europe PMC PMID:41160012},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41160012},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7248cc123f28; sha256 c28f5664ad1d43091f13086201bb81175e5b2aae1311eb2e6ac553b2bc164093},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41160012. Agents can read the archived copy with the MCP tool read_document.